BERLIN, Aug. 9, 2024 /PRNewswire/ — Mecpow, a pioneer in innovative crafting solutions, introduces the X4 series laser engraving machines, compliant with European IEC Class 1 and US FDA Class 1 safety standards, along with the MP-30 mug press, the MP-3881 heat press, and the MIG-120 and MMA-120 welding machines, designed to revolutionize possibilities for […]
Category Archives: Pr Newswire
DALIAN, China, Aug. 9, 2024 /PRNewswire/ — CBAK Energy Technology, Inc. (NASDAQ: CBAT) (“CBAK Energy,” or the “Company”) a leading lithium-ion battery manufacturer and electric energy solution provider in China, today reported its unaudited financial results for the second quarter and the first half of 2024 ended June 30, 2024. First Half of 2024 Financial […]
HYDERABAD, India, Aug. 9, 2024 /PRNewswire/ — Fun88, the leading online gaming and betting platform, is excited to celebrate its 4th anniversary with a thrilling promotion that offers players the chance to win from ₹4 Crore cash. Fun88 India Celebrates 4th Anniversary with ₹4 Crore Cash Giveaway To celebrate this milestone, Fun88 invites all players […]
‘Unseen City: Echoes of Blue’ will be available from 9 August 2024 to 5 September 2024, featuring AI-powered Manchester City player avatars and interactive tasks for fans to earn rewards Five rooms – Training Room, Strategy Room, OKX Lounge, Trophy Room and Lobby – offer a different experience in each MANCHESTER, England, Aug. 9, 2024 […]
HSINCHU, Aug. 9, 2024 /PRNewswire-FirstCall/ — ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services (“OSAT”), today reported its unaudited consolidated revenue for the month of July 2024. All U.S. dollar figures cited in this press release are based on […]
Pr Newswire
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
09
Aug
Aug
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus vaccine candidates in adults BOSTON, Aug. 08, 2024 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, […]
09
Aug
Aug
RAMAT GAN, Israel, Aug. 08, 2024 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an […]
09
Aug
Aug
VALENCIA, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial […]
09
Aug
Aug
ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) — Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2024. Revenues for the second quarter of 2024 totaled $48.8 million compared to $43.8 million for the same period in 2023. For the just ended quarter, operating income was $0.5 million, down […]
09
Aug
Aug
FDA provided clearance to SAB’s IND Appointed Lucy To as Chief Financial Officer Announced founding of a new Clinical Advisory Board MIAMI, Aug. 08, 2024 (GLOBE NEWSWIRE) — SAB BIO (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the onset […]